With increasing pressure on operating budgets, CME managers in many pharmaceutical companies are being asked if still makes sense to invest in continuing medical educational programs.
In short, the answer is “YES”. Here are five important reasons why sponsoring accredited continuing medical education programs is still a good business decision.
As a leading academic physician organization with expertise in developing innovative approaches to physician education, we believe strongly that investing in continuing medical education should remain a cornerstone activity and commitment of the pharmaceutical industry.
However, the key is doing it right, and working with a physician organization that really knows how to do this is critical for success.
For a briefing on how we can help you to take your CME/CPD programs to a higher level, and get the most from your educational investment, please contact us.